Skip to content

    PAVmed (PAVM) stock price & financials

    View PAVM earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance66.0% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $1.00M
    $0
    $8.0K
    $6.0K
    $5.0K
    -99.5%
    $52.0K
    $22.0K
    +175.0%
    $33.0K
    +450.0%
    Strengthening
    Operating Profit
    -$11.58M
    -$5.19M
    -$5.45M
    -$4.71M
    -$4.84M
    +58.2%
    -$6.80M
    -31.1%
    -$8.04M
    -47.5%
    -$7.02M
    -48.9%
    Weakening
    Net Profit
    $64.40M
    $1.43M
    $18.97M
    -$11.92M
    -$5.38M
    -108.4%
    -$1.26M
    -188.3%
    -$60.0K
    -100.3%
    -$5.38M
    +54.8%
    Weakening
    EPS
    $6.43
    $38.26
    $-22.08
    $-0.29
    -104.5%
    $-4.42
    -111.6%
    $-0.87
    +96.1%
    Weakening
    Other Income
    $72.29M
    $6.33M
    $24.07M
    -$7.61M
    -$1.17M
    -101.6%
    $4.04M
    -36.1%
    $6.97M
    -71.0%
    $424.0K
    Weakening
    Interest
    $4.0K
    $4.0K
    $3.0K
    -25.0%
    $2.0K
    -50.0%
    Weakening
    Depreciation
    Profit before Tax
    $60.71M
    $1.14M
    $18.62M
    -$12.32M
    -$6.01M
    -109.9%
    -$2.76M
    -341.4%
    -$1.06M
    -105.7%
    -$6.60M
    +46.5%
    Weakening
    MarginsOPM
    -1157.8%
    -68075.0%
    -78583.3%
    -96880.0%
    -8267.6%
    -13078.9%
    -36522.7%
    +46.3%
    -21278.8%
    +72.9%
    Strengthening
    Tax
    0.0%
    0.0%
    0.0%
    0.0%
    ReturnsROIC
    -24.3%
    -0.5%
    -7.2%
    4.5%
    2.0%
    0.5%
    0.0%
    2.0%
    -54.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$8.22M$6.22M$17.26M$77.26M$39.74M$19.64M$1.19M$1.54M$3.78M
    Short-Term Investments
    Total Current Assets$8.46M$6.55M$18.94M$82.64M$43.93M$24.50M$2.16M$2.56M$4.86M
    Net PP&E$36.3K$82.0K$1.58M$5.49M$6.05M$2.65M$2.08M$1.81M
    Goodwill
    Intangibles$2.03M$3.44M$1.42M
    Total Assets$8.50M$7.24M$19.78M$86.98M$53.98M$33.12M$30.66M$38.81M$40.21M
    LiabilitiesTotal Current Liabilities$10.97M$11.88M$7.56M$41.20M$54.18M$35.45M$14.84M$4.09M
    Short-Term Debt
    Long-Term Debt
    Long-Term Leases$1.85M$2.96M$2.25M$1.68M$1.40M
    Total Liabilities$10.97M$11.88M$20.25M$7.56M$43.05M$57.14M$37.69M$16.51M$20.91M
    EquityCommon Stock & APIC$27.1K$41.0K$64.0K$86.0K$6.0K$9.0K$1.0K$1.0K$6.0K
    Retained Earnings-$36.99M-$53.72M-$88.28M-$138.91M-$228.17M-$294.43M-$254.97M-$258.73M-$264.50M
    Total Equity-$2.31M-$3.82M$1.90M$61.67M-$9.68M-$53.83M-$2.50M$33.97M$35.05M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$8.79M-$13.36M-$21.91M-$40.59M-$70.98M-$52.04M-$33.55M-$5.21M-$7.73M
    Cash from Investing-$26.6K-$27.0K-$55.0K-$3.72M-$4.74M$758.0K-$16.18M-$31.0K-$52.0K
    Cash from Financing$15.50M$11.38M$33.01M$104.31M$38.21M$31.17M$31.28M$5.59M$7.56M
    SummaryCapital Expenditure-$26.6K-$27.0K-$55.0K-$1.47M-$1.54M-$242.0K-$55.0K-$31.0K-$52.0K
    Free Cash Flow-$8.81M-$13.38M-$21.97M-$42.06M-$72.53M-$52.28M-$33.61M-$5.24M-$7.78M
    FCF Margin-8412.0%-19237.4%-2091.1%-1120.3%-7376.1%-6948.2%

    Ratios